Browse > Article
http://dx.doi.org/10.3344/kjp.2008.21.3.173

Effects of Agmatine on GABAA Receptor Antagonist-induced Tactile Allodynia  

Lee, Youn Woo (Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine)
Ishikawa, Toshizo (Department of Neuroscience, Postgraduated Medical School of Yamaguchi University)
Publication Information
The Korean Journal of Pain / v.21, no.3, 2008 , pp. 173-178 More about this Journal
Abstract
Background: The intrathecal (IT) $GABA_A$ receptor antagonist, bicuculline (BIC), results in tactile allodynia (TA) through disinhibition in the spinal cord. Such disinhibition is considered to be an important mechanism for neuropathic pain. Agmatine, an endogenous polyamine, has a neuro-protective effect in the central nervous system. We investigated the analgesic effects and mechanisms of agmatine action on BIC-induced TA. Methods: Male Sprague-Dawley rats, weighting 250-300 g, were subjected to implantations of PE-10 into the lumbar subarachnoid space for IT drug injection. Five days after surgery, either $10{\mu}l$ of normal saline (NS) or agmatine ($30{\mu}g$ or $10{\mu}g$) in $10{\mu}l$ NS were injected 10 min prior to BIC ($10{\mu}g$) or NMDA ($5{\mu}g$). We assessed the degree of TA (graded 0: no response, 1: mild response, 2: moderate response, 3: strong response) every 5 min for 30 min. Areas under curves and degree of TA were expressed as mean ${\pm}$ SEM. Results were analyzed using one-way ANOVA followed by a Tukey test for multiple comparisons. P < 0.05 was considered significant. Results: IT BIC-induced strong TA reached its peak and plateaued between 10 to 15 min. IT NS-NMDA induced mild transient TA for up to 15 min. Preemptive IT AG attenuated IT BIC-induced TA dose dependently and preemptive IT AG10 completely abolished the IT NMDA-induced TA. Conclusions: Preemptive IT AG attenuated the IT BIC-induced TA through inhibitory actions on postsynaptic NMDA receptor activation. AG might be a viable therapeutic option in the treatment of neuropathic pain.
Keywords
agmatine; $GABA_A$ receptor antagonist; tactile allodynia;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Wang WP, Iyo AH, Miguel-Hidalgo J, Regunathan S, Zhu MY: Agmatine protects against cell damage induced by NMDA and glutamate in cultured hippocampal neurons. Brain Res 2006; 1084: 210-6   DOI   ScienceOn
2 Onal A, Delen Y, Ulker S, Soykan N: Agmatine attenuates neuropathic pain in rats: possible mediation of nitric oxide and noradrenergic activity in the brainstem and cerebellum. Life Sci 2003; 73: 413-28   DOI   ScienceOn
3 Scholz J, Broom DC, Youn DH, Mills CD, Kohno T, Suter MR, et al: Blocking caspase activity prevents transsynaptic neuronal apoptosis and the loss of inhibition in lamina II of the dorsal horn after peripheral nerve injury. J Neurosci 2005; 25: 7317-23   DOI   ScienceOn
4 Coull JA, Boudreau D, Bachand K, Prescott SA, Nault F, Siik A, et al: Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain. Nature 2003; 424: 938-42   DOI   ScienceOn
5 Tan-No K, Esashi A, Nakagawasai O, Niijima F, Furuta S, Sato T, et al: Intrathecally administered D-cycloserine produces nociceptive behavior through the activation of N-methyl-D-aspartate receptor ion-channel complex acting on the glycine recognition site. J Pharmacol Sci 2007; 104: 39-45   DOI   ScienceOn
6 Lee DH, Singh JP, Lodge D: Experiments with nitric oxide synthase inhibitors in spinal nerve ligated rats provide no evidence of a role for nitric oxide in neuropathic mechanical allodynia. Neurosci Lett 2005; 385: 179-83   DOI   ScienceOn
7 Ishikawa T, Marsala M, Sakabe T, Yaksh TL: Characterization of spinal amino acid release and touch-evoked allodynia produced by spinal glycine or GABA(A) receptor antagonist. Neuroscience 2000; 95: 781-6   DOI   ScienceOn
8 Galea E, Regunathan S, Eliopoulos V, Feinstein DL, Reis DJ: Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. Biochem J 1996; 316: 247-9   DOI
9 Garcia-Larrea L, Magnin M: Pathophysiology of neuropathic pain: review of experimental models and proposed mechanisms. Presse Med 2008; 37: 315-40   DOI   ScienceOn
10 Whiteside GT, Munglani R: Cell death in the superficial dorsal horn in a model of neuropathic pain. J Neurosci Res 2001; 64: 168-73   DOI   ScienceOn
11 Onaka M, Minami T, Nishihara I, Ito S: Involvement of glutamate receptors in strychnine- and bicuculline-induced allodynia in conscious mice. Anesthesiology 1996; 84: 1215-22   DOI   ScienceOn
12 Yaksh TL, Rudy TA: Chronic catheterization of the spinal subarachnoid space. Physiol Behav 1976; 17: 1031-6   DOI   ScienceOn
13 Fairbanks CA, Schreiber KL, Brewer KL, Yu CG, Stone LS, Kitto KF, et al: Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury. Proc Natl Acad Sci U S A 2000; 97: 10584-9   DOI
14 Engle MP, Gassman M, Sykes KT, Bettler B, Hammond DL: Spinal nerve ligation does not alter the expression or function of GABA(B) receptors in spinal cord and dorsal root ganglia of the rat. Neuroscience 2006; 138: 1277-87   DOI   ScienceOn
15 Halaris A, Plietz J: Agmatine: metabolic pathway and spectrum of activity in brain. CNS Drugs 2007; 21: 885-900   DOI   ScienceOn
16 Karadag HC, Ulugol A, Tamer M, Ipci Y, Dokmeci I: Systemic agmatine attenuates tactile allodynia in two experimental neuropathic pain models in rats. Neurosci Lett 2003; 339: 88-90   DOI   ScienceOn
17 Schoffnegger D, Heinke B, Sommer C, Sandkuuhler J: Physiological properties of spinal lamina II GABAergic neurons in mice following peripheral nerve injury. J Physiol 2006; 577: 869-78   DOI   ScienceOn
18 Zimmermann M: Pathobiology of neuropathic pain. Eur J Pharmacol 2001; 429: 23-37   DOI   ScienceOn
19 Abe K, Abe Y, Saito H: Agmatine suppresses nitric oxide production in microglia. Brain Res 2000; 872: 141-8   DOI   ScienceOn
20 Yamamoto S, Nakanishi O, Matsui T, Shinohara N, Kinoshita H, Lambert C, et al: Intrathecal adenosine A1 receptor agonist attenuates hyperalgesia without inhibiting spinal glutamate release in the rat. Cell Mol Neurobiol 2003; 23: 175-85   DOI   ScienceOn
21 Roberts JC, Grocholski BM, Kitto KF, Fairbanks CA: Pharmacodynamic and pharmacokinetic studies of agmatine after spinal administration in the mouse. J Pharmacol Exp Ther 2005; 314: 1226-33   DOI   ScienceOn
22 Moore KA, Kohno T, Karchewski LA, Scholz J, Baba H, Woolf CJ: Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord. J Neurosci 2002; 22: 6724-31   DOI
23 Zhang W, Liu LY, Xu TL: Reduced potassium-chloride co-transporter expression in spinal cord dorsal horn neurons contributes to inflammatory pain hypersensitivity in rats. Neuroscience 2008; 152: 502-10   DOI   ScienceOn
24 Zhuang ZY, Kawasaki Y, Tan PH, Wen YR, Huang J, Ji RR: Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine. Brain Behav Immun 2007; 21: 642-51   DOI   ScienceOn
25 Cizkova D, Lukacova N, Marsala M, Marsala J: Neuropathic pain is associated with alterations of nitric oxide synthase immunoreactivity and catalytic activity in dorsal root ganglia and spinal dorsal horn. Brain Res Bull 2002; 58: 161-71   DOI   ScienceOn
26 Sosnowski M, Yaksh TL: Role of spinal adenosine receptors in modulating the hyperesthesia produced by spinal glycine receptor antagonism. Anesth Analg 1989; 69: 587-92
27 Polgar E, Todd AJ: Tactile allodynia can occur in the spared nerve injury model in the rat without selective loss of GABA or GABA(A) receptors from synapses in laminae I-II of the ipsilateral spinal dorsal horn. Neuroscience 2008; 156: 193-202   DOI   ScienceOn
28 Sivilotti L, Woolf CJ: The contribution of GABAA and glycine receptors to central sensitization: disinhibition and touch-evoked allodynia in the spinal cord. J Neurophysiol 1994; 72: 169-79   DOI
29 Gadotti VM, Tibola D, Paszcuk AF, Rodrigues AL, Calixto JB, Santos AR: Contribution of spinal glutamatergic receptors to the antinociception caused by agmatine in mice. Brain Res 2006; 1093: 116-22   DOI   ScienceOn
30 Zeilhofer HU: Loss of glycinergic and GABAergic inhibition in chronic pain-contributions of inflammation and microglia. Int Immunopharmacol 2008; 8: 182-7   DOI   ScienceOn
31 Hong S, Lee JE, Kim CY, Seong GJ: Agmatine protects retinal ganglion cells from hypoxia-induced apoptosis in transformed rat retinal ganglion cell line. BMC Neurosci 2007; 8: 81   DOI   ScienceOn
32 Yaksh TL: Behavioral and autonomic correlates of the tactile evoked allodynia produced by spinal glycine inhibition: effects of modulatory receptor systems and excitatory amino acid antagonists. Pain 1989; 37: 111-23   DOI   ScienceOn
33 Olmos G, DeGregorio-Rocasolano N, Paz Regalado M, Gasull T, Assumpcioo Boronat M, Trullas R, et al: Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor. Br J Pharmacol 1999; 127: 1317-26   DOI   ScienceOn
34 Szaboo C, Bryk R, Zingarelli B, Southan GJ, Gahman TC, Bhat V, et al: Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform. Br J Pharmacol 1996; 118: 1659-68   DOI   ScienceOn